Development and Evaluation of Solid Lipid Nanoparticles of Raloxifene Hydrochloride for Enhanced Bioavailability

Raloxifene hydrochloride (RL-HCL) is an orally selective estrogen receptor modulator (SERM) with poor bioavailability of nearly 2% due to its poor aqueous solubility and extensive first pass metabolism. In order to improve the oral bioavailability of raloxifene, raloxifene loaded solid lipid nanopar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kushwaha, Anand Kumar, Vuddanda, Parameswara Rao, Karunanidhi, Priyanka, Singh, Sanjay Kumar, Singh, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817799/
https://www.ncbi.nlm.nih.gov/pubmed/24228255
http://dx.doi.org/10.1155/2013/584549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817799/
https://www.ncbi.nlm.nih.gov/pubmed/24228255
http://dx.doi.org/10.1155/2013/584549

Ejemplares similares